Gsa Capital Partners LLP Baxter International Inc Transaction History

Gsa Capital Partners LLP

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$32.87 - $43.55 $458,930 - $608,045	13,962 New	13,962 $467,000
Q4 2023 Feb 16, 2024	BUY	$31.71 - $38.95 $73,884 - $90,753	2,330 Added 14.38%	18,536 $716,000
Q3 2023 Nov 15, 2023	SELL	$37.32 - $49.29 $180,890 - $238,908	-4,847 Reduced 23.02%	16,206 $611,000
Q2 2023 Aug 14, 2023	SELL	$39.98 - $47.68 $99,190 - $118,294	-2,481 Reduced 10.54%	21,053 $959,000
Q1 2023 May 12, 2023	BUY	$37.58 - $52.57 $884,407 - $1.24 Million	23,534 New	23,534 $954,000
Q1 2021 May 10, 2021	SELL	$76.38 - $86.03 $366,624 - $412,944	-4,800 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$75.39 - $82.36 $361,872 - $395,328	4,800 New	4,800 $385,000
Q2 2020 Aug 11, 2020	SELL	$78.66 - $94.14 $535,989 - $641,469	-6,814 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$71.57 - $93.3 $487,677 - $635,746	6,814 New	6,814 $553,000
Q3 2019 Nov 12, 2019	SELL	$81.4 - $89.78 $578,591 - $638,156	-7,108 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$73.44 - $82.41 $522,011 - $585,770	7,108 New	7,108 $582,000
Q3 2018 Nov 13, 2018	SELL	$70.71 - $77.75 $1.34 Million - $1.47 Million	-18,943 Closed	0 $0
Q2 2018 Aug 09, 2018	SELL	$63.43 - $75.41 $2.43 Million - $2.89 Million	-38,314 Reduced 66.92%	18,943 $1.4 Million
Q1 2018 May 11, 2018	BUY	$62.56 - $72.26 $2.8 Million - $3.23 Million	44,735 Added 357.25%	57,257 $3.72 Million
Q4 2017 Feb 14, 2018	BUY	$61.45 - $66.05 $370,297 - $398,017	6,026 Added 92.76%	12,522 $809,000
Q3 2017 Nov 20, 2017	BUY	$59.5 - $64.61 $386,512 - $419,706	6,496	6,496 $408,000

1,006

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.7B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.